PIK3CA and cervical cancer: Together, these results reveal that expression of PIK3CA-E545K in cervical cancer cell lines promotes both cisplatin resistance and a cell migratory phenotype and that both cisplatin resistance and cell migration can be mitigated at least in part, by inhibition of the PI3K pathway using GDC-0941.